Code of Federal Regulations > Title 21 > Chapter I > Part 212 - PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

U.S. Code of Federal Regulations

Regulations most recently checked for updates: Aug 28, 2025

Subpart A [§ 212.1 - § 212.5] - Subpart A—General Provisions

Subpart B [§ 212.10 - § 212.10] - Subpart B—Personnel and Resources

Subpart C [§ 212.20 - § 212.20] - Subpart C—Quality Assurance

Subpart D [§ 212.30 - § 212.30] - Subpart D—Facilities and Equipment

Subpart E [§ 212.40 - § 212.40] - Subpart E—Control of Components, Containers, and Closures

Subpart F [§ 212.50 - § 212.50] - Subpart F—Production and Process Controls

Subpart G [§ 212.60 - § 212.61] - Subpart G—Laboratory Controls

Subpart H [§ 212.70 - § 212.71] - Subpart H—Finished Drug Product Controls and Acceptance

Subpart I [§ 212.80 - § 212.80] - Subpart I—Packaging and Labeling

Subpart J [§ 212.90 - § 212.90] - Subpart J—Distribution

Subpart K [§ 212.100 - § 212.100] - Subpart K—Complaint Handling

Subpart L [§ 212.110 - § 212.110] - Subpart L—Records